These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31182333)

  • 1. Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at U.S. academic centers.
    Phinney DG; Galipeau J;
    Cytotherapy; 2019 Jul; 21(7):782-792. PubMed ID: 31182333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data.
    Rojewski MT; Lotfi R; Gjerde C; Mustafa K; Veronesi E; Ahmed AB; Wiesneth M; Körper S; Sensebé L; Layrolle P; Hellem S; Schrezenmeier H
    Cytotherapy; 2019 Apr; 21(4):468-482. PubMed ID: 30926359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions.
    Thirlwell KL; Colligan D; Mountford JC; Samuel K; Bailey L; Cuesta-Gomez N; Hewit KD; Kelly CJ; West CC; McGowan NWA; Casey JJ; Graham GJ; Turner ML; Forbes S; Campbell JDM
    Cytotherapy; 2020 Dec; 22(12):762-771. PubMed ID: 32828673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation.
    Trento C; Bernardo ME; Nagler A; Kuçi S; Bornhäuser M; Köhl U; Strunk D; Galleu A; Sanchez-Guijo F; Gaipa G; Introna M; Bukauskas A; Le Blanc K; Apperley J; Roelofs H; Van Campenhout A; Beguin Y; Kuball J; Lazzari L; Avanzini MA; Fibbe W; Chabannon C; Bonini C; Dazzi F
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2365-2370. PubMed ID: 30031938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and cost-benefit analysis of automated bioreactor-expanded mesenchymal stem cells for clinical applications.
    Russell AL; Lefavor RC; Zubair AC
    Transfusion; 2018 Oct; 58(10):2374-2382. PubMed ID: 30203447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow-derived multipotent mesenchymal stromal cells.
    Codinach M; Blanco M; Ortega I; Lloret M; Reales L; Coca MI; Torrents S; Doral M; Oliver-Vila I; Requena-Montero M; Vives J; Garcia-López J
    Cytotherapy; 2016 Sep; 18(9):1197-208. PubMed ID: 27424149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of GMP-compliant culture media for in vitro expansion of human bone marrow mesenchymal stromal cells.
    Wuchter P; Vetter M; Saffrich R; Diehlmann A; Bieback K; Ho AD; Horn P
    Exp Hematol; 2016 Jun; 44(6):508-18. PubMed ID: 26911671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a large source of primary mesenchymal stem cells tightly adhered to bone surfaces of human vertebral body marrow cavities.
    Johnstone BH; Miller HM; Beck MR; Gu D; Thirumala S; LaFontaine M; Brandacher G; Woods EJ
    Cytotherapy; 2020 Nov; 22(11):617-628. PubMed ID: 32873509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
    Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.
    Wuchter P; Bieback K; Schrezenmeier H; Bornhäuser M; Müller LP; Bönig H; Wagner W; Meisel R; Pavel P; Tonn T; Lang P; Müller I; Renner M; Malcherek G; Saffrich R; Buss EC; Horn P; Rojewski M; Schmitt A; Ho AD; Sanzenbacher R; Schmitt M
    Cytotherapy; 2015 Feb; 17(2):128-39. PubMed ID: 24856898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pooled human serum: A new culture supplement for bioreactor-based cell therapies. Preliminary results.
    Savelli S; Trombi L; D'Alessandro D; Moscato S; Pacini S; Giannotti S; Lapi S; Scatena F; Petrini M
    Cytotherapy; 2018 Apr; 20(4):556-563. PubMed ID: 29429942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good manufacturing practice-compliant animal-free expansion of human bone marrow derived mesenchymal stroma cells in a closed hollow-fiber-based bioreactor.
    Nold P; Brendel C; Neubauer A; Bein G; Hackstein H
    Biochem Biophys Res Commun; 2013 Jan; 430(1):325-30. PubMed ID: 23146633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process.
    Lechanteur C; Briquet A; Bettonville V; Baudoux E; Beguin Y
    Cells; 2021 May; 10(6):. PubMed ID: 34073206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing and Ex Vivo Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells for the Development of an Advanced Therapy Medicinal Product for use in Humans.
    Labedz-Maslowska A; Szkaradek A; Mierzwinski T; Madeja Z; Zuba-Surma E
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Stage Preparation of Human Cartilage Grafts Generated from Bone Marrow-Derived CD271
    Petters O; Schmidt C; Henkelmann R; Pieroh P; Hütter G; Marquass B; Aust G; Schulz RM
    Stem Cells Dev; 2018 Apr; 27(8):545-555. PubMed ID: 29482445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production.
    Camilleri ET; Gustafson MP; Dudakovic A; Riester SM; Garces CG; Paradise CR; Takai H; Karperien M; Cool S; Sampen HJ; Larson AN; Qu W; Smith J; Dietz AB; van Wijnen AJ
    Stem Cell Res Ther; 2016 Aug; 7(1):107. PubMed ID: 27515308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and Manufacture of Clinical-Grade Bone Marrow-Derived Human Mesenchymal Stromal Cells.
    Miller RP; Hanley PJ
    Methods Mol Biol; 2016; 1416():301-12. PubMed ID: 27236680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues.
    Fazzina R; Iudicone P; Fioravanti D; Bonanno G; Totta P; Zizzari IG; Pierelli L
    Stem Cell Res Ther; 2016 Aug; 7(1):122. PubMed ID: 27557940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles.
    Pachler K; Lener T; Streif D; Dunai ZA; Desgeorges A; Feichtner M; Öller M; Schallmoser K; Rohde E; Gimona M
    Cytotherapy; 2017 Apr; 19(4):458-472. PubMed ID: 28188071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing.
    Rohde E; Pachler K; Gimona M
    Cytotherapy; 2019 Jun; 21(6):581-592. PubMed ID: 30979664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.